Reciprocal Regulation of Agonist and Inverse Agonist Signaling Efficacy upon Short-Term Treatment of the Human δ-Opioid Receptor with an Inverse Agonist
Open Access
- 1 January 2005
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (1) , 336-348
- https://doi.org/10.1124/mol.104.004549
Abstract
Rapid regulation of receptor signaling by agonist ligands is widely accepted, whereas short-term adaptation to inverse agonists has been little documented. In the present study, guanosine 5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding and cAMP accumulation assays were used to assess the consequences of 30-min exposure to the inverse agonist N,N-diallyl-Tyr-Aib-Aib-Phe-Leu-OH (ICI174864) (1 μM) on δ-opioid receptor signaling efficacy. ICI174864 pretreatment increased maximal effect (Emax) for the partial agonist Tyr-1,2,3,4-tetrahydroisoquinoline-Phe-Phe-OH (TIPP) at the two levels of the signaling cascade, whereas Emax values for more efficacious agonists like (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC-80) and bremazocine were increased in [35S]GTPγS binding but not in cAMP accumulation assays. Pre-exposure to ICI174864 also induced a shift to the left in dose-response curves for bremazocine and TIPP. On the other hand, Emax for the inverse agonist H-Tyr-TicΨ[CH2NH]Cha-Phe-OH was reduced in both assays, but no changes in potency were observed. For the weaker inverse agonist naloxone, Emax in [35S]GTPγS binding was drastically modified because the drug turned from inverse agonist to agonist after ICI174864 pretreatment. Likewise, ICI174864 turned from inverse agonist to agonist when tested in cAMP accumulation assays. In both cases, inversion of efficacy was concomitant with marked increase in potency for agonist effects. Together with functional changes, short-term treatment with ICI174864 reduced basal receptor phosphorylation and increased immunoreactivity for Gαi3 in membrane preparations. Functional consequences of ICI174864 pretreatment were simulated in the cubic ternary complex model by increasing receptor/G protein coupling or G protein amount available for interaction with the receptor. Taken together, these data show that inverse agonists may induce rapid regulation in receptor signaling efficacy.Keywords
This publication has 41 references indexed in Scilit:
- Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G ProteinJournal of Biological Chemistry, 2004
- β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptorsProceedings of the National Academy of Sciences, 2003
- Protean agonism at histamine H 3 receptors in vitro and in vivoProceedings of the National Academy of Sciences, 2003
- Spatial Regulation of Gαi Protein Signaling in Clathrin-Coated Membrane Microdomains Containing GAIPMolecular Pharmacology, 2003
- Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic ReceptorJournal of Biological Chemistry, 2001
- The Regulator of G Protein Signaling FamilyAnnual Review of Pharmacology and Toxicology, 2000
- Spontaneous Human B2 Bradykinin Receptor Activity Determines the Action of Partial Agonists as Agonists or Inverse AgonistsJournal of Biological Chemistry, 1999
- Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528Published by Elsevier ,1999
- A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonistMolecular Endocrinology, 1995
- Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cellsBiochemical Journal, 1994